|1.||Watson, Stanley J: 1 article (01/2006)|
|2.||Mosberg, Henry I: 1 article (01/2006)|
|3.||Jutkiewicz, Emily M: 1 article (01/2006)|
|4.||Torregrossa, Mary M: 1 article (01/2006)|
|5.||Woods, James H: 1 article (01/2006)|
|6.||Balboni, Gianfranco: 1 article (01/2006)|
01/19/2006 - "Only JOM-13 produced convulsions at doses required for antidepressant-like effects. "
01/19/2006 - "The present study examined whether a variety of peptidic delta agonists, DPDPE, JOM-13, a systemically active derivative of DPDPE, deltorphin II, and H-Dmt-Tic-NH-CH2-Bid could produce convulsions and antidepressant-like effects in the forced swim test. "
01/19/2006 - "Therefore, activation of the delta receptor by centrally administered peptidic agonists and intravenously administered JOM-13 produces behavioral antidepressant-like effects without producing convulsions, and some peptidic agonists can increase BDNF mRNA expression, however, not as consistently as the systemically active nonpeptidic agonists."
|1.||D-Penicillamine (2,5)- Enkephalin
|2.||Ala(2)- deltorphin II
|3.||Brain-Derived Neurotrophic Factor (BDNF)
|4.||delta Opioid Receptors (delta Opioid Receptor)
|5.||Messenger RNA (mRNA)